“Neuropathy is incredibly common among the aging population, regardless of disease states. There is currently no known cure for neuropathy, and most treatments address acute symptoms with no lasting impact,” says Dr. Ramona von Leden, VP of Research and Clinical Affairs for NeuFit. “NeuFit’s specialized approach to rehab focuses on supporting the function of the nervous system, and we are very excited to share that we are seeing remarkable results on patients with neuropathy.”

 Unlike conventional methods that primarily focus on structural rehabilitation, the NEUBIE targets the nervous system, the body’s control center for responses to injury or dysfunction. The use of DC over traditional alternating current (AC) in the NEUBIE device sets NeuFit apart from other electrical stimulation therapies. This promotes healing, reduces pain, and improves sensorimotor function more rapidly than AC, which can hinder effective therapy and reinforce inefficient movement patterns.